7m ago
KUALA LUMPUR, April 29 (Bernama) -- Pharmaniaga Bhd remains confident of exiting Practice Note 17 (PN17) status, supported by resilient business operations and recovery strategies that have underpinned its steady financial progress.
8m ago
KUALA LUMPUR, March 27 (Bernama) -- The Armed Forces Fund Board (LTAT) plans to reduce its strategic asset holdings from 56 per cent to 35 per cent under ‘Project Earth’ over the next three years to lower exposure while retaining control.
9m ago
KUALA LUMPUR, March 20 (Bernama) – Pharmaniaga Bhd is moving forward with its regularisation plan to exit Practice Note 17 (PN17) status following shareholders’ approval of three key resolutions at the group’s extraordinary general meeting (EGM) today.
1y ago
KUALA LUMPUR, Nov 26 (Bernama) -- Pharmaniaga Bhd has recorded a net profit of RM101.03 million in the third quarter (3Q) ended Sept 30, 2024, from a net loss of RM49.34 million in the same period last year.
1y ago
KUALA LUMPUR, Oct 19 (Bernama) -- The Armed Forces Fund Board (LTAT) is poised to seize new opportunities through the GEAR-uP initiative, which aims for government-linked investment companies (GLICs) to increase domestic direct investment to RM120 billion over the next five years, making a significant contribution to the sustainability of the nation’s economy.
1y ago
KUALA LUMPUR, Oct 18 (Bernama) -- The inaugural Malaysia Pharma and Healthcare Expo 2024 to be held at the Malaysia International Trade and Exhibition Centre (MITEC) from Oct 22-24, is set to boost Malaysia’s healthcare industry by promoting innovative products, fostering partnerships, and attracting investments in medical devices and pharmaceutical products.
1y ago
KUALA LUMPUR, Oct 10 (Bernama) -- Pharmaniaga Bhd (Pharmaniaga) has appointed Ernst & Young (EY) as its new external auditor, effective Oct 9, 2024.
1y ago
JOHOR BAHRU, Sept 30 (Bernama) -- Malaysia’s government-linked investment companies (GLICs) reiterated their joint commitment to support the MADANI Economy framework through targeted capital deployment in high-growth, high-value sectors.